Upgrade to SI Premium - Free Trial

Insys Therapeutics (INSY) Provides Upadate on FDA Advisory Committee Meeting Addressing the Co-Prescribing of Naloxone

December 18, 2018 6:12 AM
INSYS Therapeutics, Inc. (NASDAQ: INSY) today announced that Dr. Dean Mariano, senior director, clinical development and medical affairs at INSYS ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA Management Comments

Next Articles